APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Radioisotopes in Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Radioisotopes in Medicine Market Outlook and Growth Opportunities 2026

Report ID 17334423041 February 2026190 pages

Choose your research edition.

Industry ResearchRadioisotopes in Medicine Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Radioisotopes in Medicine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Radioisotopes in Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radioisotopes in Medicine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Radioisotopes in Medicine Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Radioisotopes in Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Radioisotopes in Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Radioisotopes in Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radioisotopes in Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Radioisotopes in Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Radioisotopes in Medicine market include ANSTO, China National Nuclear Corporation, Eckert & Ziegler Strahlen, IRE, Nordion, NorthStar Medical Radioisotopes, NRG, NTP Radioisotopes and Polatom, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Radioisotopes in Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Radioisotopes in Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radioisotopes in Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radioisotopes in Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Radioisotopes in Medicine Segment by Company

ANSTO

China National Nuclear Corporation

Eckert & Ziegler Strahlen

IRE

Nordion

NorthStar Medical Radioisotopes

NRG

NTP Radioisotopes

Polatom

Rosatom

SHINE Technologies

Radioisotopes in Medicine Segment by Type

Tc-99m

Iodine Radioisotopes

Cobalt-60

Others

Radioisotopes in Medicine Segment by Application

Nuclear Therapy

Equipment Radioactive Source

Diagnosis

Radioisotopes in Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Radioisotopes in Medicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Radioisotopes in Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Radioisotopes in Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Radioisotopes in Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radioisotopes in Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radioisotopes in Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radioisotopes in Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Radioisotopes in Medicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radioisotopes in Medicine industry.

Chapter 3: Detailed analysis of Radioisotopes in Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Radioisotopes in Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Radioisotopes in Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Radioisotopes in Medicine Industry Trends Table 2. Radioisotopes in Medicine Industry Drivers Table 3. Radioisotopes in Medicine Industry Opportunities and Challenges Table 4. Radioisotopes in Medicine Industry Restraints Table 5. Global Radioisotopes in Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Radioisotopes in Medicine Revenue Share by Company (2021-2026) Table 7. Global Radioisotopes in Medicine Sales Volume by Company (t) & (2021-2026) Table 8. Global Radioisotopes in Medicine Sales Volume Share by Company (2021-2026) Table 9. Global Radioisotopes in Medicine Average Price (USD/t) of Company (2021-2026) Table 10. Global Radioisotopes in Medicine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Radioisotopes in Medicine Key Company Manufacturing Base & Headquarters Table 12. Global Radioisotopes in Medicine Company, Product Type & Application Table 13. Global Radioisotopes in Medicine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Radioisotopes in Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tc-99m Table 18. Significant Companies of Iodine Radioisotopes Table 19. Significant Companies of Cobalt-60 Table 20. Significant Companies of Others Table 21. Global Radioisotopes in Medicine Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 22. Global Radioisotopes in Medicine Sales Volume by Type (2021-2026) & (t) Table 23. Global Radioisotopes in Medicine Sales Volume by Type (2027-2032) & (t) Table 24. Global Radioisotopes in Medicine Sales Volume Share by Type (2021-2026) Table 25. Global Radioisotopes in Medicine Sales Volume Share by Type (2027-2032) Table 26. Global Radioisotopes in Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Radioisotopes in Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Radioisotopes in Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Radioisotopes in Medicine Sales Value Share by Type (2021-2026) Table 30. Global Radioisotopes in Medicine Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Nuclear Therapy Table 32. Significant Companies of Equipment Radioactive Source Table 33. Significant Companies of Diagnosis Table 34. Global Radioisotopes in Medicine Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 35. Global Radioisotopes in Medicine Sales Volume by Application (2021-2026) & (t) Table 36. Global Radioisotopes in Medicine Sales Volume by Application (2027-2032) & (t) Table 37. Global Radioisotopes in Medicine Sales Volume Share by Application (2021-2026) Table 38. Global Radioisotopes in Medicine Sales Volume Share by Application (2027-2032) Table 39. Global Radioisotopes in Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Radioisotopes in Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Radioisotopes in Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Radioisotopes in Medicine Sales Value Share by Application (2021-2026) Table 43. Global Radioisotopes in Medicine Sales Value Share by Application (2027-2032) Table 44. Global Radioisotopes in Medicine Sales by Region: 2021 VS 2025 VS 2032 (t) Table 45. Global Radioisotopes in Medicine Sales by Region (2021-2026) & (t) Table 46. Global Radioisotopes in Medicine Sales Market Share by Region (2021-2026) Table 47. Global Radioisotopes in Medicine Sales by Region (2027-2032) & (t) Table 48. Global Radioisotopes in Medicine Sales Market Share by Region (2027-2032) Table 49. Global Radioisotopes in Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Radioisotopes in Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Radioisotopes in Medicine Sales Value Share by Region (2021-2026) Table 52. Global Radioisotopes in Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Radioisotopes in Medicine Sales Value Share by Region (2027-2032) Table 54. Global Radioisotopes in Medicine Market Average Price (USD/t) by Region (2021-2026) Table 55. Global Radioisotopes in Medicine Market Average Price (USD/t) by Region (2027-2032) Table 56. Global Radioisotopes in Medicine Sales by Country: 2021 VS 2025 VS 2032 (t) Table 57. Global Radioisotopes in Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Radioisotopes in Medicine Sales by Country (2021-2026) & (t) Table 59. Global Radioisotopes in Medicine Sales Market Share by Country (2021-2026) Table 60. Global Radioisotopes in Medicine Sales by Country (2027-2032) & (t) Table 61. Global Radioisotopes in Medicine Sales Market Share by Country (2027-2032) Table 62. Global Radioisotopes in Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Radioisotopes in Medicine Sales Value Market Share by Country (2021-2026) Table 64. Global Radioisotopes in Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Radioisotopes in Medicine Sales Value Market Share by Country (2027-2032) Table 66. ANSTO Company Information Table 67. ANSTO Business Overview Table 68. ANSTO Radioisotopes in Medicine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 69. ANSTO Radioisotopes in Medicine Product Portfolio Table 70. ANSTO Recent Development Table 71. China National Nuclear Corporation Company Information Table 72. China National Nuclear Corporation Business Overview Table 73. China National Nuclear Corporation Radioisotopes in Medicine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. China National Nuclear Corporation Radioisotopes in Medicine Product Portfolio Table 75. China National Nuclear Corporation Recent Development Table 76. Eckert & Ziegler Strahlen Company Information Table 77. Eckert & Ziegler Strahlen Business Overview Table 78. Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolio Table 80. Eckert & Ziegler Strahlen Recent Development Table 81. IRE Company Information Table 82. IRE Business Overview Table 83. IRE Radioisotopes in Medicine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. IRE Radioisotopes in Medicine Product Portfolio Table 85. IRE Recent Development Table 86. Nordion Company Information Table 87. Nordion Business Overview Table 88. Nordion Radioisotopes in Medicine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Nordion Radioisotopes in Medicine Product Portfolio Table 90. Nordion Recent Development Table 91. NorthStar Medical Radioisotopes Company Information Table 92. NorthStar Medical Radioisotopes Business Overview Table 93. NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolio Table 95. NorthStar Medical Radioisotopes Recent Development Table 96. NRG Company Information Table 97. NRG Business Overview Table 98. NRG Radioisotopes in Medicine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. NRG Radioisotopes in Medicine Product Portfolio Table 100. NRG Recent Development Table 101. NTP Radioisotopes Company Information Table 102. NTP Radioisotopes Business Overview Table 103. NTP Radioisotopes Radioisotopes in Medicine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. NTP Radioisotopes Radioisotopes in Medicine Product Portfolio Table 105. NTP Radioisotopes Recent Development Table 106. Polatom Company Information Table 107. Polatom Business Overview Table 108. Polatom Radioisotopes in Medicine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Polatom Radioisotopes in Medicine Product Portfolio Table 110. Polatom Recent Development Table 111. Rosatom Company Information Table 112. Rosatom Business Overview Table 113. Rosatom Radioisotopes in Medicine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. Rosatom Radioisotopes in Medicine Product Portfolio Table 115. Rosatom Recent Development Table 116. SHINE Technologies Company Information Table 117. SHINE Technologies Business Overview Table 118. SHINE Technologies Radioisotopes in Medicine Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. SHINE Technologies Radioisotopes in Medicine Product Portfolio Table 120. SHINE Technologies Recent Development Table 121. Key Raw Materials Table 122. Raw Materials Key Suppliers Table 123. Radioisotopes in Medicine Distributors List Table 124. Radioisotopes in Medicine Customers List Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Radioisotopes in Medicine Product Image Figure 2. Global Radioisotopes in Medicine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radioisotopes in Medicine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Radioisotopes in Medicine Sales (2021-2032) & (t) Figure 5. Global Radioisotopes in Medicine Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Radioisotopes in Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tc-99m Image Figure 10. Iodine Radioisotopes Image Figure 11. Cobalt-60 Image Figure 12. Others Image Figure 13. Global Radioisotopes in Medicine Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 14. Global Radioisotopes in Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Radioisotopes in Medicine Sales Volume Share by Type (2021-2032) Figure 16. Global Radioisotopes in Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Radioisotopes in Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Radioisotopes in Medicine Sales Value Share by Type (2021-2032) Figure 19. Nuclear Therapy Image Figure 20. Equipment Radioactive Source Image Figure 21. Diagnosis Image Figure 22. Global Radioisotopes in Medicine Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 23. Global Radioisotopes in Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Radioisotopes in Medicine Sales Volume Share by Application (2021-2032) Figure 25. Global Radioisotopes in Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Radioisotopes in Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Radioisotopes in Medicine Sales Value Share by Application (2021-2032) Figure 28. Global Radioisotopes in Medicine Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 29. Global Radioisotopes in Medicine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Radioisotopes in Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Radioisotopes in Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Radioisotopes in Medicine Sales Value (2021-2032) & (US$ Million) Figure 33. North America Radioisotopes in Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Radioisotopes in Medicine Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Radioisotopes in Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Radioisotopes in Medicine Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Radioisotopes in Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Radioisotopes in Medicine Sales Value (2021-2032) & (US$ Million) Figure 39. South America Radioisotopes in Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Radioisotopes in Medicine Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Radioisotopes in Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Radioisotopes in Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Radioisotopes in Medicine Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Radioisotopes in Medicine Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Tc-99m
  • Iodine Radioisotopes
  • Cobalt-60
  • Others
Applications
  • Nuclear Therapy
  • Equipment Radioactive Source
  • Diagnosis
Companies covered
  • ANSTO
  • China National Nuclear Corporation
  • Eckert & Ziegler Strahlen
  • IRE
  • Nordion
  • NorthStar Medical Radioisotopes
  • NRG
  • NTP Radioisotopes
  • Polatom
  • Rosatom
  • SHINE Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radioisotopes in Medicine Sales Value (2021-2032)
  4. 1.2.2 Global Radioisotopes in Medicine Sales Volume (2021-2032)
  5. 1.2.3 Global Radioisotopes in Medicine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Radioisotopes in Medicine Market Dynamics
  1. 2.1 Radioisotopes in Medicine Industry Trends
  2. 2.2 Radioisotopes in Medicine Industry Drivers
  3. 2.3 Radioisotopes in Medicine Industry Opportunities and Challenges
  4. 2.4 Radioisotopes in Medicine Industry Restraints
3 Radioisotopes in Medicine Market by Company
  1. 3.1 Global Radioisotopes in Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Radioisotopes in Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Radioisotopes in Medicine Sales Volume by Company (2021-2026)
  4. 3.4 Global Radioisotopes in Medicine Average Price by Company (2021-2026)
  5. 3.5 Global Radioisotopes in Medicine Company Ranking (2024-2026)
  6. 3.6 Global Radioisotopes in Medicine Company Manufacturing Base and Headquarters
  7. 3.7 Global Radioisotopes in Medicine Company Product Type and Application
  8. 3.8 Global Radioisotopes in Medicine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Radioisotopes in Medicine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Radioisotopes in Medicine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Radioisotopes in Medicine Market by Type
  1. 4.1 Radioisotopes in Medicine Type Introduction
  2. 4.1.1 Tc-99m
  3. 4.1.2 Iodine Radioisotopes
  4. 4.1.3 Cobalt-60
  5. 4.1.4 Others
  6. 4.2 Global Radioisotopes in Medicine Sales Volume by Type
  7. 4.2.1 Global Radioisotopes in Medicine Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Radioisotopes in Medicine Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Radioisotopes in Medicine Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Radioisotopes in Medicine Sales Value by Type
  11. 4.3.1 Global Radioisotopes in Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Radioisotopes in Medicine Sales Value by Type (2021-2032)
  13. 4.3.3 Global Radioisotopes in Medicine Sales Value Share by Type (2021-2032)
5 Radioisotopes in Medicine Market by Application
  1. 5.1 Radioisotopes in Medicine Application Introduction
  2. 5.1.1 Nuclear Therapy
  3. 5.1.2 Equipment Radioactive Source
  4. 5.1.3 Diagnosis
  5. 5.2 Global Radioisotopes in Medicine Sales Volume by Application
  6. 5.2.1 Global Radioisotopes in Medicine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Radioisotopes in Medicine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Radioisotopes in Medicine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Radioisotopes in Medicine Sales Value by Application
  10. 5.3.1 Global Radioisotopes in Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Radioisotopes in Medicine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Radioisotopes in Medicine Sales Value Share by Application (2021-2032)
6 Radioisotopes in Medicine Regional Sales and Value Analysis
  1. 6.1 Global Radioisotopes in Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radioisotopes in Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global Radioisotopes in Medicine Sales by Region: 2021-2026
  4. 6.2.2 Global Radioisotopes in Medicine Sales by Region (2027-2032)
  5. 6.3 Global Radioisotopes in Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Radioisotopes in Medicine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Radioisotopes in Medicine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Radioisotopes in Medicine Sales Value by Region (2027-2032)
  9. 6.5 Global Radioisotopes in Medicine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Radioisotopes in Medicine Sales Value (2021-2032)
  12. 6.6.2 North America Radioisotopes in Medicine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Radioisotopes in Medicine Sales Value (2021-2032)
  15. 6.7.2 Europe Radioisotopes in Medicine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Radioisotopes in Medicine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Radioisotopes in Medicine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Radioisotopes in Medicine Sales Value (2021-2032)
  21. 6.9.2 South America Radioisotopes in Medicine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Radioisotopes in Medicine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Radioisotopes in Medicine Sales Value Share by Country, 2025 VS 2032
7 Radioisotopes in Medicine Country-level Sales and Value Analysis
  1. 7.1 Global Radioisotopes in Medicine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Radioisotopes in Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Radioisotopes in Medicine Sales by Country (2021-2032)
  4. 7.3.1 Global Radioisotopes in Medicine Sales by Country (2021-2026)
  5. 7.3.2 Global Radioisotopes in Medicine Sales by Country (2027-2032)
  6. 7.4 Global Radioisotopes in Medicine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Radioisotopes in Medicine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Radioisotopes in Medicine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Radioisotopes in Medicine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Radioisotopes in Medicine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Radioisotopes in Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ANSTO
  2. 8.1.1 ANSTO Company Information
  3. 8.1.2 ANSTO Business Overview
  4. 8.1.3 ANSTO Radioisotopes in Medicine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ANSTO Radioisotopes in Medicine Product Portfolio
  6. 8.1.5 ANSTO Recent Developments
  7. 8.2 China National Nuclear Corporation
  8. 8.2.1 China National Nuclear Corporation Company Information
  9. 8.2.2 China National Nuclear Corporation Business Overview
  10. 8.2.3 China National Nuclear Corporation Radioisotopes in Medicine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 China National Nuclear Corporation Radioisotopes in Medicine Product Portfolio
  12. 8.2.5 China National Nuclear Corporation Recent Developments
  13. 8.3 Eckert & Ziegler Strahlen
  14. 8.3.1 Eckert & Ziegler Strahlen Company Information
  15. 8.3.2 Eckert & Ziegler Strahlen Business Overview
  16. 8.3.3 Eckert & Ziegler Strahlen Radioisotopes in Medicine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolio
  18. 8.3.5 Eckert & Ziegler Strahlen Recent Developments
  19. 8.4 IRE
  20. 8.4.1 IRE Company Information
  21. 8.4.2 IRE Business Overview
  22. 8.4.3 IRE Radioisotopes in Medicine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 IRE Radioisotopes in Medicine Product Portfolio
  24. 8.4.5 IRE Recent Developments
  25. 8.5 Nordion
  26. 8.5.1 Nordion Company Information
  27. 8.5.2 Nordion Business Overview
  28. 8.5.3 Nordion Radioisotopes in Medicine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Nordion Radioisotopes in Medicine Product Portfolio
  30. 8.5.5 Nordion Recent Developments
  31. 8.6 NorthStar Medical Radioisotopes
  32. 8.6.1 NorthStar Medical Radioisotopes Company Information
  33. 8.6.2 NorthStar Medical Radioisotopes Business Overview
  34. 8.6.3 NorthStar Medical Radioisotopes Radioisotopes in Medicine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolio
  36. 8.6.5 NorthStar Medical Radioisotopes Recent Developments
  37. 8.7 NRG
  38. 8.7.1 NRG Company Information
  39. 8.7.2 NRG Business Overview
  40. 8.7.3 NRG Radioisotopes in Medicine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 NRG Radioisotopes in Medicine Product Portfolio
  42. 8.7.5 NRG Recent Developments
  43. 8.8 NTP Radioisotopes
  44. 8.8.1 NTP Radioisotopes Company Information
  45. 8.8.2 NTP Radioisotopes Business Overview
  46. 8.8.3 NTP Radioisotopes Radioisotopes in Medicine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 NTP Radioisotopes Radioisotopes in Medicine Product Portfolio
  48. 8.8.5 NTP Radioisotopes Recent Developments
  49. 8.9 Polatom
  50. 8.9.1 Polatom Company Information
  51. 8.9.2 Polatom Business Overview
  52. 8.9.3 Polatom Radioisotopes in Medicine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Polatom Radioisotopes in Medicine Product Portfolio
  54. 8.9.5 Polatom Recent Developments
  55. 8.10 Rosatom
  56. 8.10.1 Rosatom Company Information
  57. 8.10.2 Rosatom Business Overview
  58. 8.10.3 Rosatom Radioisotopes in Medicine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Rosatom Radioisotopes in Medicine Product Portfolio
  60. 8.10.5 Rosatom Recent Developments
  61. 8.11 SHINE Technologies
  62. 8.11.1 SHINE Technologies Company Information
  63. 8.11.2 SHINE Technologies Business Overview
  64. 8.11.3 SHINE Technologies Radioisotopes in Medicine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 SHINE Technologies Radioisotopes in Medicine Product Portfolio
  66. 8.11.5 SHINE Technologies Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Radioisotopes in Medicine Value Chain Analysis
  2. 9.1.1 Radioisotopes in Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Radioisotopes in Medicine Sales Mode & Process
  6. 9.2 Radioisotopes in Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Radioisotopes in Medicine Distributors
  9. 9.2.3 Radioisotopes in Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst